XML 19 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Discontinued Operations: Closure of Direct Dose Rx
3 Months Ended
Mar. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]  
DISCONTINUED OPERATIONS: Closure of Direct Dose Rx

4. DISCONTINUED OPERATIONS: Closure of Direct Dose Rx

 

On June 24, 2021, the Company’s Board of Directors decided to close its pharmacy operations, Rubicon DTP LLC, doing business as Direct Dose Rx. Immediately thereafter, Direct Dose Rx began transitioning its customers to other providers and began the process of closing its operations. Direct Dose was launched as a start-up pharmacy primarily to deliver medications and vitamins to patients being discharged from skilled nursing facilities. Based on the Company’s review and analysis of ASC 205-20 Presentation of Discontinued Operations it concluded to present the discontinued operations separately. 

 

   Three months ended
March 31,
 
   2022   2021 
   (in thousands) 
     
Revenues (discontinued operations)  $0   $234 
Operating (income) expense (discontinued operations)  $(14)  $329 
Income (loss) from discontinued operations, net of taxes  $14   $(95)